Equities

Trinity Biotech PLC

Trinity Biotech PLC

Actions
Health CareMedical Equipment and Services
  • Price (USD)1.56
  • Today's Change0.195 / 14.34%
  • Shares traded338.22k
  • 1 Year change-42.99%
  • Beta1.1795
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Trinity Biotech plc is an Ireland-based commercial stage biotechnology company. The Company is focused on human diagnostics and diabetes management solutions, including wearable biosensors. The Company develops, acquires, manufactures and markets diagnostic systems, including both reagents and instrumentation, for the point-of-care and clinical laboratory segments of the diagnostic market and has also entered the wearable biosensor industry. It intends to develop a range of biosensor devices and related services, starting with a continuous glucose monitoring product. Its products are used to detect infectious diseases and to quantify the level of Hemoglobin A1c and other chemistry parameters in serum, plasma and whole blood. The Company sells direct in the United States and through a network of international distributors and strategic partners in over 75 countries worldwide.

  • Revenue in USD (TTM)58.65m
  • Net income in USD-22.29m
  • Incorporated1992
  • Employees380.00
  • Location
    Trinity Biotech PLCIda Business ParkBray, Co Wicklow, IrelandBRAY 18IrelandIRL
  • Phone+353 12769800
  • Fax+353 12769888
  • Websitehttps://www.trinitybiotech.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
TRIB:NSQ since
announced
Transaction
value
Metabolomic Diagnostics LtdDeal completed24 Sep 202424 Sep 2024Deal completed24.40%--
Waveform Technologies Inc-Continuous Glucose Monitoring AssetsAnnounced31 Jan 202431 Jan 2024Announced-28.34%21.50m
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
BioRegenx Inc634.81k-727.95k11.96m10.00--0.7029--18.83-0.001-0.0010.00160.01780.0617----63,481.00-7.07---8.46--74.90---114.67--0.1547-8.800.0977---47.25---629.37------
Innovative Eyewear Inc1.53m-7.86m12.19m11.00--1.61--7.97-11.01-11.012.054.810.17791.9715.91139,070.90-91.45---96.06---2.46---514.10--12.85--0.00--74.67---17.28------
PAVmed Inc3.83m-67.35m12.38m107.00------3.23-8.17-8.170.4595-7.740.0823--29.4535,785.05-155.93-154.56---1,152.82-77.59---1,895.64-8,764.890.5529-8.161.74--550.40--25.76--55.51--
QT Imaging Holdings Inc0.00-4.02m13.29m----0.6114-----0.3999-0.39990.001.010.00-------12.32---16.60--------------0.3042-------45.07------
Autonomix Medical Inc-100.00bn-100.00bn13.47m5.00--2.13----------0.2749----------------------------0.1647-------674.99------
Scientific Industries Inc10.45m-7.76m13.50m63.00--1.16--1.29-0.9231-0.92311.171.110.73431.139.08165,942.90-54.50---62.11--45.41---74.22--3.15--0.00--------------
Bionoid Pharma Inc0.001.35m13.50m13.000.2204--9.98--1.131.130.00-0.1744-----------506.64--------------327.24---------31.55--26.01--
REMSleep Holdings Inc144.88k-1.81m14.18m6.00--24.66--97.90-0.0012-0.00120.00010.00040.081.694.75---99.82-152.40-122.32-317.98-491.08---1,246.94-2,317.521.47-43.580.1207---36.48--12.13--28.26--
Cutera Inc169.19m-148.97m14.48m430.00------0.0856-7.46-7.468.46-10.730.45722.083.86393,460.50-40.25-22.00-51.64-30.728.1847.63-88.05-27.242.17-31.342.05---15.865.47-97.76--85.87--
LiveCare Inc0.00-2.34m15.16m----6.43-----0.1411-0.14110.000.04630.00-------424.83---550.62-------------8.180.1888-------344.86------
Trinity Biotech plc (ADR)58.65m-22.29m15.46m380.00------0.2637-2.74-2.747.23-19.240.70521.693.74154,347.40-26.80-20.30-35.44-29.5434.2839.92-38.01-29.860.8936-2.161.46---9.10-10.1515.41---31.08--
SeaStar Medical Holding Corp0.00-33.23m17.02m12.00---------21.41-21.410.00-2.140.00----0.00-1,145.80-----------------9.51---------115.19------
Golden Valley Development Inc0.00-92.53k17.10m0.00---------11.17-11.170.00-0.02110.00-------7,710.83-------------3,073.27---3.96--------45.48------
Orgenesis Inc662.00k-29.02m18.27m146.00------27.60-8.68-8.680.2005-3.300.027278.295.384,534.25-122.18---1,312.10---101.06---4,489.28--0.0741-5.85-----98.53-50.94-271.82---17.71--
Beyond Air Inc1.78m-58.35m18.56m107.00--1.14--10.41-1.65-1.650.04850.35140.02981.706.8716,663.55-104.22-78.25-137.64-99.91-78.30---3,493.78-6,152.992.42-38.110.4666-----31.57-7.93--152.05--
Data as of Oct 08 2024. Currency figures normalised to Trinity Biotech PLC's reporting currency: US Dollar USD

Institutional shareholders

49.75%Per cent of shares held by top holders
HolderShares% Held
Perceptive Advisors LLCas of 30 Apr 20242.72m35.60%
Hunter Associates Investment Management LLCas of 30 Jun 2024333.71k4.37%
Renaissance Technologies LLCas of 30 Jun 2024265.45k3.47%
Stonehill Capital Management LLCas of 31 Mar 2024248.40k3.25%
Whitefort Capital Management, LPas of 31 Mar 202481.90k1.07%
Acadian Asset Management LLCas of 30 Jun 202472.11k0.94%
Moss Adams Wealth Advisors LLCas of 30 Jun 202425.67k0.34%
Cambridge Investment Research Advisors, Inc.as of 30 Jun 202422.28k0.29%
Becker Capital Management, Inc.as of 31 Mar 202418.00k0.24%
Virtu Americas LLCas of 30 Jun 202414.27k0.19%
More ▼
Data from 31 Mar 2024 - 30 Jun 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.